Bruker BioSciences Corp. (BRKR) CEO Frank H Laukien buys 100,000 Shares

Author's Avatar
May 08, 2009
CEO/President, 10% Owner of Bruker BioSciences Corp. (BRKR, Financial) Frank H Laukien buys 100,000 shares of BRKR on 05/07/2009 at an average price of $7.28 a share.

As of February 26 2008 the renamed BRUKER CORPORATION has become the parent company of the entire Bruker group of companies. After the closing of the acquisition of the Bruker BioSpin Group Bruker Corporation now operates in two segments the life science and analytical (LSA) systems segment and the international advanced superconductor (IAS) segment. Bruker BioSciences Corp. has a market cap of $1.24 billion; its shares were traded at around $7.58 with a P/E ratio of 16.1 and P/S ratio of 1.1.

Recent Trades of Bruker BioSciences Corp. by CEO:
  • Buy: CEO/President, 10% Owner Frank H Laukien bought 100,000 shares of BRKR stock on 05/07/2009 at the average price of $7.28; the price of the stock has increased by 4.12% since.

  • Buy: CEO/President, 10% Owner Frank H Laukien bought 125,000 more shares of BRKR stock on 03/09/2009 at the average price of $4.2; the price of the stock has increased by 80.48% since.

  • Buy: CEO/President, Director, 10% Owner Frank H Laukien bought 37,914 more shares of BRKR stock on 12/16/2008 at the average price of $4.22; the price of the stock has increased by 79.62% since.

  • Buy: CEO/President, Director, 10% Owner Frank H Laukien bought 70,736 more shares of BRKR stock on 12/16/2008 at the average price of $4.34; the price of the stock has increased by 74.65% since.

  • Buy: CEO/President, Director, 10% Owner Frank H Laukien bought 100,000 more shares of BRKR stock on 12/15/2008 at the average price of $4.19; the price of the stock has increased by 80.91% since.



Recent Trades of Bruker BioSciences Corp. by CFO:
  • Buy: CFO William J Knight bought 5,000 shares of BRKR stock on 11/20/2008 at the average price of $3.73; the price of the stock has increased by 103.22% since.